96 related articles for article (PubMed ID: 23117442)
1. Incidence of severe asthmatic reactions after challenge exposure to occupational agents.
Vandenplas O; D'Alpaos V; Evrard G; Jamart J
Chest; 2013 May; 143(5):1261-1268. PubMed ID: 23117442
[TBL] [Abstract][Full Text] [Related]
2. Inhalation challenges with occupational agents: threshold duration of exposure.
D'Alpaos V; Vandenplas O; Evrard G; Jamart J
Respir Med; 2013 May; 107(5):739-44. PubMed ID: 23415625
[TBL] [Abstract][Full Text] [Related]
3. Do Low Molecular Weight Agents Cause More Severe Asthma than High Molecular Weight Agents?
Meca O; Cruz MJ; Sánchez-Ortiz M; González-Barcala FJ; Ojanguren I; Munoz X
PLoS One; 2016; 11(6):e0156141. PubMed ID: 27280473
[TBL] [Abstract][Full Text] [Related]
4. Different Severity and Severity Predictors in Early-Onset and Late-Onset Asthma: A Taiwanese Population-Based Study.
Wu TJ; Chen BY; Lee YL; Hsiue TR; Wu CF; Guo YL
Respiration; 2015; 90(5):384-92. PubMed ID: 26418355
[TBL] [Abstract][Full Text] [Related]
5. SABINA: An Overview of Short-Acting β
Janson C; Menzies-Gow A; Nan C; Nuevo J; Papi A; Quint JK; Quirce S; Vogelmeier CF
Adv Ther; 2020 Mar; 37(3):1124-1135. PubMed ID: 31981105
[TBL] [Abstract][Full Text] [Related]
6. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
7. Impact of occupational exposures on exacerbation of asthma: a population-based asthma cohort study.
Kim JL; Henneberger PK; Lohman S; Olin AC; Dahlman-Höglund A; Andersson E; Torén K; Holm M
BMC Pulm Med; 2016 Nov; 16(1):148. PubMed ID: 27842581
[TBL] [Abstract][Full Text] [Related]
8. Asthma severity and exposure to occupational asthmogens.
Le Moual N; Siroux V; Pin I; Kauffmann F; Kennedy SM;
Am J Respir Crit Care Med; 2005 Aug; 172(4):440-5. PubMed ID: 15961697
[TBL] [Abstract][Full Text] [Related]
9. Drug utilization and asthma control among young Danish adults with asthma. Analyses of trends and determinants.
Davidsen JR
Dan Med J; 2012 Aug; 59(8):B4501. PubMed ID: 22849986
[TBL] [Abstract][Full Text] [Related]
10. Specific inhalation challenge: the relationship between response, clinical variables and lung function.
Hu C; Cruz MJ; Ojanguren I; de Homdedeu M; Gonzalez-Barcala FJ; Munoz X
Occup Environ Med; 2017 Aug; 74(8):586-591. PubMed ID: 28270447
[TBL] [Abstract][Full Text] [Related]
11. Distinct temporal patterns of immediate asthmatic reactions due to high- and low-molecular-weight agents.
Malo JL; Ghezzo H; L'archevêque J
Clin Exp Allergy; 2012 Jul; 42(7):1021-7. PubMed ID: 22702501
[TBL] [Abstract][Full Text] [Related]
12. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
[TBL] [Abstract][Full Text] [Related]
13. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
Chan J; Hui RL; Spence MM
J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
[TBL] [Abstract][Full Text] [Related]
14. Occupational asthma phenotypes identified by increased fractional exhaled nitric oxide after exposure to causal agents.
Lemiere C; NGuyen S; Sava F; D'Alpaos V; Huaux F; Vandenplas O
J Allergy Clin Immunol; 2014 Nov; 134(5):1063-7. PubMed ID: 25262466
[TBL] [Abstract][Full Text] [Related]
15. Five-fold increase in use of inhaled corticosteroids over 18 years in the general adult population in west Sweden.
Ekerljung L; Bjerg A; Bossios A; Axelsson M; Torén K; Wennergren G; Lötvall J; Lundbäck B
Respir Med; 2014 May; 108(5):685-93. PubMed ID: 24685491
[TBL] [Abstract][Full Text] [Related]
16. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
[TBL] [Abstract][Full Text] [Related]
17. Asthma pharmacotherapy.
Schofield ML
Otolaryngol Clin North Am; 2014 Feb; 47(1):55-64. PubMed ID: 24286679
[TBL] [Abstract][Full Text] [Related]
18. Principal findings of systematic reviews of acute asthma treatment in childhood.
Castro-Rodriguez JA; J Rodrigo G; E Rodríguez-Martínez C
J Asthma; 2015; 52(10):1038-45. PubMed ID: 26303207
[TBL] [Abstract][Full Text] [Related]
19. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.
Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L
Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561
[TBL] [Abstract][Full Text] [Related]
20. Treatment with inhaled mometasone furoate reduces short-acting β(2) agonist claims and increases adherence compared to fluticasone propionate in asthma patients.
Navaratnam P; Friedman HS; Urdaneta E
Value Health; 2011; 14(2):339-46. PubMed ID: 21402302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
